CD34 and mantle cell lymphoma: After MCL injury was treated by transplantation of MCL-MSCs and/or CD34+ cells, the results demonstrated that the group with concurrent administration of MCL-MSCs and CD34+ cells showed improved ligament healing, characterized by grossly diminished swelling, more regularly aligned fibers, increased type I collagen deposition and neovascularization, and higher tensile strength.